ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

A Metabolic Reprogramming Amino Acid Polymer as an Immunosurveillance Activator and Leukemia Targeting Drug Carrier for T-Cell Acute Lymphoblastic Leukemia

Li, Changzheng; You, Xinru; Xu, Xi; Wu, Binghuo; Liu, Yuye; Tong, Tong; Chen, Jie; Li, Yishan; Dai, Chunlei; Ye, Zhitao; Tian, Xiaobin; Wei, Yan; Hao, Zechen; Jiang, Linjia*; Wu, Jun*; Zhao, Meng*南方医科大学; 中山大学
Advanced Science2022-3DOI: 10.1002/advs.202104134
25被引11阅读
引用收藏
分享

摘要

Compromised immunosurveillance leads to chemotherapy resistance and disease relapse of hematological malignancies. Amino acid metabolism regulates immune responses and cancer; however, a druggable amino acid metabolite to enhance antitumor immunosurveillance and improve leukemia targeting-therapy efficacy remains unexplored. Here, an L-phenylalanine polymer, Metabolic Reprogramming Immunosurveillance Activation Nanomedicine (MRIAN), is invented to effectively target bone marrow (BM) and activate the immune surveillance in T-cell acute lymphoblastic leukemia (T-ALL) by inhibiting myeloid-derived suppressor cells (MDSCs) in T-ALL murine model. Stable-isotope tracer and in vivo drug distribution experiments show that T-ALL cells and MDSCs have enhanced cellular uptake of L-phenylalanine and MRIANs than normal hematopoietic cells and progenitors. Therefore, MRIAN assembled Doxorubicin (MRIAN-Dox) specifically targets T-ALL cells and MDSCs but spare normal hematopoietic cells and hematopoietic stem and progenitor cells with enhanced leukemic elimination efficiency. Consequently, MRIAN-Dox has reduced cardiotoxicity and myeloablation side effects in treating T-ALL mice. Mechanistically, MRIAN degrades into L-phenylalanine, which inhibits PKM2 activity and reduces ROS levels in MDSCs to disturb their immunosuppressive function and increase their differentiation toward normal myeloid cells. Overall, a novel amino acid metabolite nanomedicine is invented to treat T-ALL through the combination of leukemic cell targeting and immunosurveillance stimulation.

学科与关键词

关键词
amino acid metabolismimmunosurveillanceMetabolic Reprogramming Immunosurveillance Activation Nanomedicine (MRIAN)myeloid-derived suppressor cells (MDSCs)T-cell acute lymphoblastic leukemia (T-ALL)
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Advanced Science
发表日期
2022-03
卷期
第 9 卷, 第 9 期
页码
2104134
DOI
10.1002/advs.202104134
语言
ENGLISH
期刊等级
1区
成果收录
SCIE
资助标注
National Key Research and Development Program of China [2017YFA0103403, 2018YFA0107200]; Key Research and Development Program of Guangdong Province [2019B020234002]; NSFC [81822001, 52173150, 82170112, 82100129, 51973243]; Shenzhen Foundation of Science and Technology [JCYJ20170818103626421]; Guangdong Innovative and Entrepreneurial Research Team Program [2019ZT08Y485]; Sanming Project of Medicine in Shenzhen [SZSM201911004]; Natural Science Foundation of Guangdong [2021B1515020012]; Advanced Medical Technology Center, The First Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-sen University

作者

  • L

    Li, Changzheng (第一作者)

    sun yat sen univ

  • Y

    You, Xinru

    sun yat sen univ

查看全部 16 位作者收起作者
  • X

    Xu, Xi

    southern med univ

  • W

    Wu, Binghuo

    sun yat sen univ

  • L

    Liu, Yuye

    sun yat sen univ

  • T

    Tong, Tong

    sun yat sen univ

  • C

    Chen, Jie

    sun yat sen univ

  • L

    Li, Yishan

    sun yat sen univ

  • D

    Dai, Chunlei

    sun yat sen univ

  • Y

    Ye, Zhitao

    sun yat sen univ

  • T

    Tian, Xiaobin

    sun yat sen univ

  • W

    Wei, Yan

    sun yat sen univ

  • H

    Hao, Zechen

    sun yat sen univ

  • J

    Jiang, Linjia (通讯)

    sun yat sen univ

  • W

    Wu, Jun (通讯)

    sun yat sen univ

  • Z

    Zhao, Meng (通讯)

    sun yat sen univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417